NHS Greater Glasgow & Clyde

What NHS Greater Glasgow & Clyde does

NHS Greater Glasgow & Clyde (NHSGGC) is the largest NHS health board in Scotland and the United Kingdom, operating as a statutory public sector body under the National Health Service (Scotland) Act 1978 and accountable to NHS Scotland and the Scottish Government. It delivers comprehensive publicly funded healthcare — free at the point of delivery — to the resident population of the Greater Glasgow and Clyde region through a network of 14 hospital sites and ancillary health centres, clinics, mental health facilities, and maternity and child health services. Major facilities include the Queen Elizabeth University Hospital, Glasgow Royal Infirmary, the Beatson West of Scotland Cancer Centre, the Royal Hospital for Children, and the Royal Alexandra Hospital. Customer-facing activity runs through NHS referral pathways, GP registration, A&E presentation, and self-referral routes, with no commercial product distribution or pricing model.

The board's service portfolio spans emergency and acute care, elective surgery, cancer diagnostics and treatment, cardiology (including a newly digitised heart failure pathway via an AstraZeneca partnership), maternity and paediatrics, mental health, sexual health, and addictions recovery. Recent service-line development has focused on decentralised and AI-augmented diagnostics: a January 2026 UK-first mobile Community Diagnostic Vehicle programme offering doorstep X-ray, ultrasound, and phlebotomy; participation in the £1.9 million Vanguard Path study validating the ArteraAI Prostate Biopsy Assay; and a data partnership with TileBio and the NHS West of Scotland Innovation Hub to train a large-scale AI pathology foundation model on over 2 million whole slide images.

The business model is publicly funded through Scottish Government NHS allocations with no commercial revenue stream. The board is not investable in the conventional PE/VC sense and has no parent commercial entity, subsidiaries, or private shareholding. Key operational risks evidenced in the data include an ongoing corporate homicide investigation into environmental conditions at Queen Elizabeth University Hospital, recent cybersecurity breaches affecting legacy NHS Scotland GP practice domains, and a 13.4% diagnostic radiographer vacancy rate that the Community Diagnostic Vehicle programme is explicitly designed to mitigate.

Name

NHS Greater Glasgow & Clyde

Legal name

NHS Greater Glasgow & Clyde

Website

https://nhsggc.org.uk

Company type

Private

Founded year

1880

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

NHS Greater Glasgow & Clyde is the largest NHS health board in Scotland, delivering publicly funded hospital, community, mental health, maternity, and specialist care to the regional population through 14 hospital sites, including the Queen Elizabeth University Hospital and the Beatson Cancer Centre.

Ownership category

akta.pro rank

Product category

Public Hospital Healthcare Services

NAICS

General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (622110), General Medical and Surgical Hospitals (62211), Hospitals (622)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Safety-Net & Public Hospitals (HLAFAAAD)

Keywords

• Public healthcare services
• Hospital care services
• Emergency medical services
• Specialist clinical services
• Community health services

Headquarters

HQ city

Glasgow

HQ country

United Kingdom

HQ region

Europe

Offices14 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Distribution channels4 records

Marketing channels7 records

Core offering

NHS Greater Glasgow & Clyde is the largest NHS health board in the United Kingdom, operating a network of major hospitals, community health centres, and specialist clinical services across the Greater Glasgow and Clyde region. It delivers comprehensive public healthcare — emergency and acute care, elective surgery, cancer treatment, maternity, mental health, and community diagnostics — free at the point of delivery and funded through UK government NHS allocations.

Product overview

NHS Greater Glasgow & Clyde is a public healthcare system operating as a single integrated health board rather than a product company. The organization provides healthcare services through a network of 11 major hospitals, health centres, clinics, and specialist services including mental health, maternity, sexual health, and community-based care. Key services include the 'Right Care, Right Place' urgent care navigation, a UK-first mobile community diagnostic vehicle, and AI-powered diagnostic partnerships with TileBio (cancer pathology AI) and AstraZeneca (heart failure diagnostics), plus participation in the ArteraAI prostate cancer Vanguard Path study.

Differentiator

Problem solved

Functional benefit

Products and services

• Main Hospital Network
• Right Care, Right Place
• Mental Health Services
• Maternity and Child Health Services
• Sexual Health (Sandyford)
• Alcohol and Drug Recovery Services

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Partnerships

Seven partnerships are on record, tiered core, minor and support.

• AstraZenecacoreStrategic or Co-development Partner · 10 April 2025AstraZeneca partnered with NHS Greater Glasgow & Clyde to digitise heart failure diagnostics in Scotland, reducing wait times for diagnostic echocardiograms from one year to under six weeks. This partnership is part of AstraZeneca's global initiative to improve early diagnosis of chronic, rare, and oncological diseases through healthcare system partnerships.
• TileBiocoreStrategic or Co-development PartnerNHS Greater Glasgow & Clyde has a data partnership with TileBio (University of Glasgow spin-out) and the NHS West of Scotland Innovation Hub to train and validate TileBio's AI pathology foundation model on millions of digitised whole slide images. No patient-identifiable data is used. TileBio secured £1.6M seed funding for this initiative.
• NHS West of Scotland Innovation HubcoreStrategic or Co-development PartnerThe NHS West of Scotland Innovation Hub is a data partner alongside NHS Greater Glasgow & Clyde, providing the infrastructure and data governance framework for TileBio's AI pathology model training on millions of digitised pathology images.
• University of Oxford (Vanguard Path study)minorStrategic or Co-development PartnerNHS Greater Glasgow & Clyde is one of three NHS sites participating in the £1.9 million Vanguard Path study led by University of Oxford researchers, testing the ArteraAI Prostate Biopsy Assay on biopsies from over 4,000 men. The other sites are North Bristol NHS Trust and Oxford University Hospitals NHS Foundation Trust.
• John O'Byrne FoundationminorOthersFormer Yorkhill Hospital patient John O'Byrne launched a foundation to help sick children in hospital, following his own experiences as a patient and volunteer at Yorkhill. The foundation represents a charitable community partnership linked to NHSGGC's legacy children's hospital.
• Public Services Delivery Scotland's Cyber Centre of ExcellencesupportTechnology or IntegrationNHS Greater Glasgow and Clyde's cybersecurity team is working with Public Services Delivery Scotland's Cyber Centre of Excellence to address a cybersecurity breach affecting legacy NHS Scotland domains, including The New Surgery in Kilmacolm, which was hacked to distribute inappropriate content.
• InnoScot HealthcoreStrategic or Co-development PartnerHealthcare innovation organization InnoScot Health is promoting NHS Greater Glasgow & Clyde's mobile community diagnostic vehicle programme, describing it as having 'huge potential for national rollout.' InnoScot Health supports the initiative aimed at addressing a 13.4% vacancy rate for diagnostic radiographers.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• NHS Lothian: Regional NHS Scotland health board serving Edinburgh and the Lothians. Directly comparable as a similarly sized Scottish NHS board delivering acute, community, and specialist hospital services to a defined regional population.
• NHS Grampian: Regional NHS Scotland health board serving the north-east of Scotland. Operates a similar acute and community hospital network with comparable funding model, workforce constraints, and patient population scale.
• NHS Tayside: Regional NHS Scotland health board serving Tayside. Comparable in scope (acute hospitals, teaching, community services) and governance structure to NHSGGC, operating under the same NHS Scotland framework.
• NHS Fife: Regional NHS Scotland health board serving Fife. Smaller-scale direct peer operating acute and community services under the same statutory framework and funding model as NHSGGC.

Broad incumbents

• Barts Health NHS Trust: One of the largest NHS trusts in England, operating multiple acute hospitals across east London. Comparable in operating a multi-site teaching hospital network with significant emergency and specialist workload, though under NHS England.
• King's College Hospital NHS Foundation Trust: Major London teaching hospital trust delivering acute, specialist, and tertiary services. Comparable to NHSGGC's teaching hospital sites (e.g., Glasgow Royal Infirmary, QEUH) in complexity and case mix.
• Imperial College Healthcare NHS Trust: London-based acute teaching trust with five hospitals including St Mary's and Hammersmith. Comparable scale and academic hospital footprint to NHSGGC's major teaching sites.
• NHS Greater Manchester Integrated Care Board: Large English NHS integrated care system covering a comparable urban population. Comparable in scale of population served and breadth of services, though structured under NHS England rather than NHS Scotland governance.

Emerging players

• Royal Marsden NHS Foundation Trust: UK's specialist cancer hospital, comparable in role to NHSGGC's Beatson West of Scotland Cancer Centre. Relevant peer for oncology service lines and AI pathology partnerships where both operate at the cutting edge of cancer care.
• Great Ormond Street Hospital for Children NHS Foundation Trust: Specialist paediatric hospital in London, directly comparable to NHSGGC's Royal Hospital for Children. Relevant peer for tertiary paediatric service delivery and research partnerships.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/nhsggc
• YouTubeyoutube.com/nhsggc
• Facebookfacebook.com/nhsggc
• Instagraminstagram.com/nhsggc
• LinkedInlinkedin.com/company/nhs-greater-glasgow-and-clyde

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NHS Greater Glasgow & Clyde